Reactive oxygen species (ROS) may cause cellular damage and oxidative stress-induced cell death. Autophagy, an evolutionarily conserved intracellular catabolic process, is executed by autophagy (ATG) proteins, including the autophagy initiation kinase Unc-51-like kinase (ULK1)/ATG1. Although autophagy has been implicated to have both cytoprotective and cytotoxic roles in the response to ROS, the role of individual ATG proteins, including ULK1, remains poorly characterized. In this study, we demonstrate that ULK1 sensitizes cells to necrotic cell death induced by hydrogen peroxide (H 2 O 2 ). Moreover, we demonstrate that ULK1 localizes to the nucleus and regulates the activity of the DNA damage repair protein poly (ADP-ribose) polymerase 1 (PARP1) in a kinase-dependent manner. By enhancing PARP1 activity, ULK1 contributes to ATP depletion and death of H 2 O 2 -treated cells. Our study provides the first evidence of an autophagy-independent prodeath role for nuclear ULK1 in response to ROS-induced damage. On the basis of our data, we propose that the subcellular distribution of ULK1 has an important role in deciding whether a cell lives or dies on exposure to adverse environmental or intracellular conditions. Cell Death and Differentiation (2016) 23, 216-230; doi:10.1038/cdd.2015; published online 3 July 2015
It is typically upregulated under conditions of perceived stress and in response to cellular damage. The consequence of autophagy activation -whether cytoprotective or cytotoxicappears to depend on the cell type and the nature and extent of stress. Although most studies indicate a cytoprotective role for autophagy, some evidence suggests that it contributes to cell death in response to oxidative stress. [13] [14] [15] [16] [17] Studies have also indicated that autophagy may be suppressed in response to oxidative stress, thereby sensitizing certain cells to apoptosis. 18, 19 Unc-51-like kinase/autophagy 1 (ULK1/ATG1) is a mammalian serine-threonine kinase that regulates flux through the autophagy pathway by activating the VPS34 PI(3) kinase complex and facilitating ATG9-dependent membrane recycling. 20 Results from two studies suggest that ULK1 expression is altered in response to oxidative stress, and that the corresponding effects on autophagy contribute to cell death. 18, 21 For example, p53-mediated upregulation of ULK1 and increase in autophagy promote cell death in osteosarcoma cells exposed to sublethal doses of camptothecin, 21 yet mutant p53-mediated suppression of ULK1 impairs autophagic flux and promotes apoptosis in selenite-treated NB4 cells. 18 Here we investigated the role of ULK1 in cells exposed to H 2 O 2 .
Results ULK1 facilitates nonapoptotic cell death after H 2 O 2 treatment. To study the role of ULK1 following ROSinduced cellular damage, we treated wild-type (WT) and Ulk1-knockout (KO), SV40-transformed murine embryonic fibroblasts (MEFs) with H 2 O 2 , a diffusible nonradical oxidant that has been extensively used to study ROS damage in vitro. 22 Trypan blue-exclusion assays revealed a significant (Po0.01) delay in cell death in Ulk1-KO MEFs ( Figure 1a ). Overexpression of full-length WT ULK1 in Ulk1-KO MEFs, at levels comparable to those used to rescue their defect in autophagy, 23 restored sensitivity to H 2 O 2 -induced cell death ( Figure 1b) . Similarly, overexpression of ULK1 in 293 T cells, which have low endogenous levels of ULK1, increased sensitivity to H 2 O 2 -induced cell death (Figure 1c) . These results suggest a prodeath role for ULK1 in response to oxidative stress. Reverse-transcription (RT)-qPCR analyses indicated a transient decline in steady-state levels of Ulk1 mRNA in H 2 O 2 -treated MEFs ( Figure 1d) ; however, ULK1 protein levels were unchanged (Figures 1e and f) . ULK1-mediated cell death in response to H 2 O 2 occurs in an autophagy-independent manner. Next, we sought to determine the contribution of autophagy to H 2 O 2 -induced cell death in MEFs. We examined levels of lipidated LC3 (i.e., LC3II) and P62 by immunoblot analyses in the presence or the absence of the lysosomal inhibitor bafilomycin A1. LC3 is a ubiquitin-like molecule that is conjugated to phosphatidylethanolamine (i.e., lipidated) on induction of autophagy and undergoes lysosomal degradation as autophagosomes mature. 24 P62 is a ubiquitin-binding scaffold protein that is degraded by autophagy and accumulates when autophagy is inhibited. 24 H 2 O 2 treatment increased LC3II, but adding bafilomycin A did not enhance that effect; P62 levels were also unchanged (Figures 2a-c ). These findings suggest that H 2 O 2 mildly impairs autophagic flux in MEFs. We used a quantitative, reproducible firefly luciferase-based assay, which specifically exploits the autophagy-dependent turnover of LC3b, to measure flux through the autophagy pathway. 23 Unlike the ULK1-dependent LC3 degradation induced by starvation (Figure 2e) , 23 H 2 O 2 did not stimulate autophagymediated LC3 degradation in either WT or Ulk1-KO MEFs (Figure 2d ).
We then examined the contribution of autophagy to cell viability in H 2 O 2 -treated WT and Ulk1-deficient MEFs. Atg7 is an E1-like ligase that promotes elongation of autophagosome membranes by facilitating the conjugation of ATG5 to ATG12 and that of LC3 to phosphatidylethanolamine. 25 The level of RNAi-mediated knockdown of Atg7, confirmed by RT-qPCR (Supplementary Figure S2) , impaired starvation-induced LC3 degradation in WT MEFs, although not to the same level as in Ulk1-deficient MEFs (Figure 2e) , and increased susceptibility to cell death after starvation comparable with that observed in Ulk1-deficient MEFs (Figure 2g) . 26, 27 Atg7 knockdown did not protect against H 2 O 2 -induced cell death in WT or Ulk1-KO MEFs (Figure 2f ). Instead, MEFs with Atg7 knockdown or KO were more sensitive to H 2 O 2 treatment than were WT MEFs (Figures 1f and h) . Thus, the minimal levels of H 2 O 2 -induced autophagy may have a cytoprotective role, and the cytotoxic effects of ULK1 are unlikely to be due to altered flux through the canonical (ATG7-dependent) autophagy pathway.
As ULK1 has been implicated in an ATG7-independent autophagy, 28 we examined H 2 O 2 -treated WT and Ulk1-deficient MEFs by transmission electron microscopy. WT MEFs treated with H 2 O 2 for 5 h had abnormal nuclear morphology, with chromatin segregated to the periphery and mitochondria that were swollen and contained small, electrondense inclusions (Figure 2i ). Necrotic cells with disrupted plasma membranes were also frequent in the WT sample ( Figure 2i ) but not in Ulk1-KO samples (Figure 2i ). Although H 2 O 2 -treated Ulk1-KO MEFs showed mitochondrial abnormalities similar to those in intact WT MEFs, their nuclei were more similar to those of untreated MEFs (Figure 2i ). Autophagosomes and autophagolysosomes were rare in WT and Ulk1-KO samples at 2 and 5 h after H 2 O 2 treatment. These findings indicate that the H 2 O 2 -induced ULK1-dependent cell death is not caused by excessive induction of autophagy or impaired autophagosome maturation; it occurs via an autophagy-independent mechanism. ULK1 interacts with PARP1. To elucidate the mechanism of ULK1-dependent cell death, we immunoprecipitated flagtagged ULK1 from whole-cell extracts derived from 293T cells and identified interacting partners by liquid chromatographytandem mass spectrometry (MS/MS). PARP1, a nuclear enzyme involved in DNA repair and cell death, 29 was among the ULK1-interacting partners (Figure 3a and Supplementary  Tables S1 and S2 ). The ULK1-PARP1 interaction was confirmed by immunoblot detection of endogenous PARP1 in flag-ULK1 (Figure 3b ) and GFP-ULK1 immunoprecipitates (Supplementary Figure S3) , and that of overexpressed ULK1 from GFP-PARP immunoprecipitates in 293T cells (Figure 3c ). ULK1 shares a significant homology with ULK2, a related ATG1 family member that has also been implicated in autophagy. 30 Although PARP1 interacted with ULK2 (data not shown), we could not confirm this interaction using green fluorescent protein (GFP)-tagged ULK2 (Supplementary Figure S3) ; therefore, subsequent studies focused on the function of the PARP1-ULK1 interaction.
ULK1 presumably functions primarily in the cytosol. However, PARP1 is almost exclusively located in the nucleus. 31 Therefore, we examined the subcellular distribution of endogenous ULK1 in MEFs. Immunoblot analyses showed that although ULK1 is more abundant in the cytoplasm, it is also present in the nucleus (Figure 3d ). We then immunoprecipitated ULK1 from nuclear extracts and assessed the presence of endogenous PARP1. Immunoblot analyses confirmed the ULK1-PARP1 interaction in nuclear extracts (Figure 3e ). 32 Although PARP1 participates in the DNA repair process, excessive DNA damage results in PARP1 hyperactivation, ATP depletion, and cell death from bioenergetic collapse. 33 Consistent with PARP1 being the major source of PAR polymers in H 2 O 2 -treated MEFs, the increase in PARylated proteins after H 2 O 2 treatment was abolished with PARP1 knockdown (Figure 4a ). PARP1 knockdown also inhibited cell death in WT MEFs (Figures 4b and c ). PARP1 hyperactivation associated with H 2 O 2 treatment decreases intracellular ATP levels in WT MEFs. 33 The decline in cellular ATP after H 2 O 2 treatment was attenuated in WT MEFs pretreated with the PARP inhibitor 3,4-dihydro-5[4-(1-piperindinyl)butoxy]-1(2H)-isoquinoline (DPQ) and in Ulk1-KO MEFs (Figure 4d ). Thus, PARP1 is central to the bioenergetics crisis and cell death resulting from H 2 O 2 treatment.
ULK1 regulates PARP1 activity. PARP1 localizes to the nucleoli in live or mildly fixed cells and redistributes to the nucleoplasm on excessive DNA damage. 34, 35 To gain insight into the functional consequence of the ULK1-PARP1 interaction, we monitored GFP-labeled PARP1 (PARP1-GFP) localization in WT and Ulk1-KO MEFs subjected to H 2 O 2 or ultraviolet (UV) radiation, both of which damage DNA. 36, 37 As expected, transiently transfected PARP1-GFP was concentrated in the nucleoli of WT MEFs under normal conditions and migrated to the nucleoplasm after exposure to H 2 O 2 (Figures 5a and b) or UV radiation (Figure 5b ). Although the DNA damage was comparable in UVirradiated WT and Ulk1-KO MEFs, as suggested by the similar levels of γH2AX (a biomarker of DNA damage) 38 up to 4 h after treatment (Supplementary Figure S4) , PARP1-GFP was retained in the nucleoli of Ulk1-KO MEFs exposed to UV radiation or H 2 O 2 (Figures 5a and b) .
Next, we performed fluorescence recovery after photobleaching experiments to determine whether PARP1 mobility was altered by ULK1. Neither the rate of fluorescence recovery nor the percent recovery after photobleaching nucleoli (Supplementary Figures S5a-c Figure S5d) .
A recent study demonstrated that PARP1 activation is required for DNA damage-induced suppression of rRNA synthesis within the nucleoli and relocation of PARP1 into the nucleoplasm. 39 (Figure 5g) . Thus, the retention of PARP1 within the nucleoli of Ulk1-KO MEFs subjected to H 2 O 2 treatment or UV irradiation is probably caused by reduced PARP1 activation resulting from the absence of ULK1.
ULK1 activity is required for nuclear localization and interaction with PARP1. To characterize the determinants of ULK1 nuclear localization, we examined the subcellular localization of overexpressed ULK1 by immunofluorescence confocal microscopy. Although GFP-ULK1 (Supplementary Figure S6a Ulk1:
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: Figure S6c) . These data suggest that low levels of ULK1 are present in the nuclei of cells under normal growth conditions, and that H 2 O 2 increases the levels of nuclear ULK1 in a subset of cells. Moreover, the ULK1-dependent increase in nuclear
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MEFs peptide: (Table 1) were submitted to ConsensusPathDB for induced network-module gene-set analysis to visualize previously described relationships among the proteins. Interactions between ULK1 and the HSP90 chaperone complex, AMPK subunits, 14-3-3, and RB1CC1 have been previously validated. 23, 27 (b) Whole-cell extracts (WCEs) and anti-flag immunoprecipitates from 293T cells transfected with Flag-GFP or Flag-ULK1 were subjected to immunoblot analyses by using antibodies against the indicated proteins (PARP1, ULK1, and GFP). PARP1 was detected in the Flag-ULK1 immunoprecipitates but not in Flag-GFP immunoprecipitates. (c) WCEs and anti-GFP immunoprecipitates from 293 T cells cotransfected with Flag-ULK1 and either GFP or PARP1-GFP were subjected to immunoblot analyses by using antibodies against the indicated proteins. ULK1 was more abundant in the PARP1-GFP immunoprecipitates than in the GFP immunoprecipitates. (d) Nuclear (N) and cytosolic (C) fractions were prepared from Ulk1 +/+ and Ulk1 −/− MEFs and subjected to immunoblot analyses using antibodies against PARP1, GAPDH, and ULK1. ULK1 immunoreactivity in the nuclear-enriched fraction shows the presence of ULK1 in the nucleus. (e) Nuclear fractions prepared from Ulk1 +/+ and Ulk1 −/− MEFs were subjected to IP with an anti-ULK1 antibody (N17, Santa Cruz) in the presence or the absence of an antibody-specific blocking peptide. Endogenous PARP1 immunoprecipitated with endogenous ULK1 from nuclear extracts prepared from WT MEFs 
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Flux through the autophagy pathway was monitored using a luciferase-LC3-based reporter that quantifies the rate of autophagy-mediated LC3 turnover, as described previously. 23 The assays were performed with WT (Ulk1 +/+ ) and Ulk1-deficient (Ulk1 −/− ) MEFs stably expressing Luc-LC3 (LC3) or the control construct luciferase-LC3-G120A (G120A), which cannot be modified by PE and, therefore, cannot be degraded by the autophagy pathway. Paired WT and Ulk1-deficient MEFs stably expressing Luc-LC3 or Luc-G120A were treated with vehicle or 500 μM H 2 O 2 in CM for the indicated times (d). Paired WTand Ulk1-deficient MEFs stably expressing Luc-LC3 or Luc-G120A were transfected with nontargeting (Ctrl) or Atg7 siRNA for 48 h, washed twice in either prewarmed CM (used for normalization of data) or EBSS, and then incubated in the respective media for the indicated times (e). Data are represented as the ratio of Luc-LC3 to Luc-G120A (mean ± S.D.). Autophagy-mediated degradation of Luc-LC3 is observed in amino acid-deprived cells but not in cells treated with H 2 O 2 . (f) WT (Ulk1 Figure S6b) .
Next, we introduced point mutations into a predicted importin α-dependent nuclear-localization signal (NLS) in murine ULK1 (aa261-289) that was identified using the cNLS Mapper (Supplementary Figure S7a) . 40 Individual arginine (R) and lysine (K) residues within the 29-residue NLS were replaced with alanines (A) and the resulting mutants were screened for their ability to disrupt ULK1's nuclear localization. Immunofluorescence microscopy of transiently transfected 293T cells revealed that unlike WT ULK1, the R266A-ULK1 mutant was excluded from the nuclei, even after H 2 O 2 treatment, and did not alter nuclear localization of PARP1-GFP (Figure 6c ). Confocal microscopic assessment of the nuclear localization of kinase-inactive (KI, K46A) 23 and AMPK-resistant (4SA) 27 ULK1 mutants revealed that the KI-ULK1 mutant was excluded from the nuclei, similar to the R266A mutant; however, the 4SA mutant behaved in a manner similar to WT ULK1 (Supplementary Figure S7b) .
Fractionation studies showed a marked reduction in the amount of R266A and KI-ULK1 mutants in the nuclear fractions compared with that of the 4SA mutant or WT ULK1; the levels remained unchanged after H 2 O 2 treatment (Figure 6d ). Consistent with having defective nuclear localization, the KI mutant, which still interacts with ATG13, 23 failed to promote ATG13's translocation into the nucleus to the same extent as WT ULK1 did (Supplementary Figure S6c) . In addition to defective nuclear localization, or perhaps as a consequence of it, the R266A and KI mutants were not efficiently incorporated into PARP1-GFP immunoprecipitates (Figure 6e ).
Immunoblot analyses (Figures 6d and e) also revealed that the electrophoretic mobility of the R266A-ULK1 mutant was comparable to that of the KI mutant; both migrated faster than WT ULK1 and the 4SA mutant. The structure of ULK1 crystals demonstrates that the R266 residue interacts with the glutamic acid (E) at 191 via a buried salt bridge (Supplementary Figures  S8a-c) . 41 Both residues are conserved among closely related kinases (Supplementary Figure S8b) and the R266A mutation may alter folding of the kinase domain and impair ULK1 catalytic activity. 42 ATG13 is phosphorylated at serine (S) 318 in a ULK1-dependent manner. Therefore, to test the effect of the R266A mutation on ULK1's catalytic activity, we cotransfected 293T cells with individual ULK1 constructs (WT, R266A, KI, and 4SA) and ATG13, and then examined phosphorylated S318 levels by immunoblot analyses. Although phosphorylated ATG13 was detected in cells expressing WT ULK1 or the 4SA mutant, it was not detected in cells expressing the KI or the R266A-ULK1 mutants (Figure 6f) . Thus, ULK1's catalytic activity is required for its localization to the nucleus and interaction with PARP1.
ULK1 activity is required for ULK1-mediated PARP1 activation. To assess the importance of ULK1's activity and nuclear localization on the regulation of PARP1 activity, we examined PARP1's localization and activity in Ulk1-deficient MEFs stably expressing either WT ULK1 or the KI mutant. PARP1 localization experiments were performed using Ulk1-KO MEFs with stable Ulk2 knockdown; 27 these cells were prepared without using GFP, thereby enabling us to detect transiently transfected PARP1-GFP by confocal Ulk1-KO/Ulk2 shRNA and Ulk1-deficient MEFs expressing the KI-ULK1 mutant had lower levels of PARylated proteins after H 2 O 2 treatment than did those expressing WT ULK1 (Figures 7b and c) . WT ULK1 in Ulk1-KO/Ulk2 shRNA and Ulk1-deficient MEFs restored sensitivity to H 2 O 2 -induced cell death, whereas expression of the KI mutant did not (Figures 7d and e) . Similar results were obtained in 293T cells transfected with either WT ULK1 or the R266A mutant (Figures 7f and h) . Immunoblot analyses demonstrated lower levels of PARylated proteins in 293T cells expressing the ULK1 R266A mutant than in those expressing comparable levels of WT ULK1 ( Figure 7f) ; ectopic expression of WT ULK1 but not that of the R266A mutant sensitized 293T cells to H 2 O 2 -induced ATP depletion (Figure 7g ) and cell death (Figure 7h) . Therefore, kinase-dependent localization of ULK1 to the nucleus and ULK1 interaction with PARP1 are required for PARP1 hyperactivation, ATP depletion, and cell death in H 2 O 2 -treated cells.
Ulk1 -/-+ULK1
Finally, to determine whether the effect of ULK1 was specific to H 2 O 2 -induced cell death, we assessed the viability of 293T cells transiently overexpressing WT ULK1 or one of several ULK1 mutants before treatment with β-lapachone or camptothecin. The orthonapthoquinone β-lapachone inhibits the catalytic activity of DNA topoisomerase 1, thereby causing PARP1 hyperactivation. [43] [44] [45] The efficacy of β-lapachone as an anticancer agent is being evaluated in multiple Phase II trials (http://www.cancer.gov/clinicaltrials). The AMPK-resistant 4SA mutation sensitized cells to a sublethal dose of β-lapachone to the same extent as WT ULK1 did. Conversely, the KI and R266A mutants did not sensitize the cells (Figures 7i and k) . Thus, we observed good correlation between nuclear localization and ULK1 sensitization to β-lapachone-induced cell death. Similar responses were observed in cells treated with camptothecin (Figures 7j and k, and Supplementary Figure S9 ).
Discussion
Here we demonstrated that ULK1 potentiates cell death after oxidative stress and PARP1 activation. Although cytoprotective and cytotoxic roles have been ascribed to ULK1's autophagic function, 21, 23, 46 our results provide evidence that ULK1 acts as a prodeath molecule in an Atg7-independent manner. In Drosophila, overexpression of Atg1 promotes cell death through an apoptotic pathway, 47 whereas in human osteosarcoma cells treated with camptothecin the p53-dependent upregulation of ULK1 potentiates cell death. 21 Our results indicate that ULK1 is one of several ATG proteins that induces cell death through autophagy-independent pathways. 48 They do not exclude the possibility that ULK1 overexpression promotes apoptosis or autophagy-mediated cell death under certain circumstances but rather provide an alternative mechanism for ULK1-dependent cell death that is associated with nuclear localization of ULK1.
Previous studies showed that ULK1 expression can be modulated in a p53-dependent manner in response to oxidative stress; however, we bypassed the p53-dependent changes in ULK1 expression and detected a novel function of ULK1 that is unrelated to its autophagy-inducing function.
We identified a pool of ULK1 within the nucleus that interacts with PARP1 and enhances its activation after exposure to ROS-inducing and/or DNA-damaging agents. Decreased PARP1 activation in Ulk1-deficient cells was manifested by reduced redistribution of PARP1, decreased accumulation of PARylated proteins, reduced ATP depletion, and reduced cell death after exposure to lethal doses of H 2 O 2 . These findings reveal an uncharacterized role for nuclear ULK1 in regulating PARP1 activity and highlight the importance of ULK1's catalytic activity in facilitating nuclear translocation of ULK1. ATG13 may accompany ULK1 into the nucleus, and given the role of ATG13 in stabilizing ULK1 protein it is likely to be that ATG13 regulates PARP1 activity; however, additional studies are required to determine whether ATG13 is a component of the ULK1-PARP1 complex or simply maintains ULK1 in a stable conformation until it transfers to the PARP1-containing complex. Increased localization of ULK1 in nuclei after H 2 O 2 treatment may limit the autophagic response, whereas promoting PARP1-dependent necrosis under conditions resulting in excessive ROS (Figure 8 ), especially in cells lacking p53. Therefore, we propose that the contribution of ULK1 in health and disease may be its ability to regulate not only autophagy but also PARP1 activity.
Balancing the regulation of autophagy and PARP1-mediated cell death by ULK1 is most likely relevant to the development and/or treatment of certain cancers. ULK1 overexpression in patients with esophageal squamous cell carcinoma, 49 hepatocellular carcinoma, 50 or breast cancer 46 is associated with poor prognosis. Conventional wisdom posits that autophagy confers a survival advantage to tumor cells within the nutrient-and oxygen-deprived tumor microenvironment. Our results show that it may also facilitate PARP1 hyperactivation and necrotic cell death, which can induce a protumor inflammatory response. 51 The heterogeneity of ULK1 localization within a given tumor population may be beneficial for overall tumor growth. Although ULK1 overexpression is associated with poor prognosis with current treatment regimens, the observation that ULK1 expression sensitizes cells to ROS-induced cell death could be exploited to select appropriate ROS-inducing drugs to advance treatment of patients with ULK1-overexpressing tumors.
Materials and Methods
Plasmid constructs. Flag-tagged ULK1 (gift from Dr. Toshifumi Tomoda), pMXs-IP-EGFP-ULK1 (gift from Noboru Mizushima, Addgene plasmid 38193), 52 pMXs-IP-EGFP-ULK2 (gift from Noboru Mizushima, Addgene plasmid 38201), 52 HA-tagged ATG13 (gift from Dr. Do-Hyung Kim), 53 and PARP1-GFP (gift from Dr. Guy G Poirier) 54 were described previously. ULK1 kinase-inactive (KI, K46A), AMPK phosphorylation site (4SA), and nuclear localization-defective (R266A) mutants were created via site-directed mutagenesis by using the Quikchange II site-directed mutagenesis kit (Agilent Technologies, Santa Clara, CA, USA). The pBlueScript SK + plasmid containing mULK1 cDNA was used as the starting template with the following mutagenic oligonucleotides (altered codons are underlined and are in bold):
Ulk1-K46A: 5′-CGACCTGGAGGTGGCCGTCGCATGCATTAACAAGAAGA-3′ and 5′-CTTCTTGTTAATGCATGCGACGGCCACCTCCAGGTCG-3′; Ulk1-S467A: 5′-ATCC GAAGGTCAGGGGCCACCAGCCCCCTG-3′ and 5′-CAGGGGGCTGGTGGCCCCAC TCCTTCGGAT-3′; ULK1-S555A: 5′-TGCCGCCTGCACGCTGCCCCTAACCTGTCC-3′ and 5′-GGACAGGTTAGGGGCAGCGTGCAGGCGGCA-3′; Ulk1-T574A: 5′-CTGC CTAAGCCCCCAGCAGACCCACTGGGA-3′ and 5′-TCCCAGTGGGTCTGCTGG GGGCTTAGGCAG-3′; Ulk1-S637A: 5′-TTCCCCAAAACCCCCGCCTCTCAGAAT TTG-3′ and 5′-CAAATTCTGAGAGGCGGGGGTTTTGGGGAA-3′; ULK1-R266A: 5′-CGGAACCACAAGGACGCCATGGACTTTGAT-3′ and 5′-ATCAAAGTCCATGGC GTCCTTGTGGTTCCG-3′.
Each ULK1 mutant was subcloned into the 5′-and 3′-EcoRI restriction enzyme sites of the MSCV-IRES-GFP-MII (gift from Dr. Terrence Geiger) 55 reader to measure the relative light units (RLUs). Concentration-response data were analyzed by using a custom script written in the R language (www.R-project.org). RLU values were first normalized by subtracting the median RLU of the DMSO control wells, then fit to the four-parameter log-logistic function ('Hill equation'): y = y 0 +(y Fin − y 0 )/(1+(EC 50 /x) − Hill), where y is the activity, x is the log concentration, EC 50 is the log concentration at the half-maximal observed response, and y 0 and y Fin are the responses at zero and infinite concentrations, respectively.
Generation of MEFs. MEFs were prepared from the E12.5 embryos of Atg7
Embryos were collected, washed twice with PBS, incubated in trypsin, and then separated into single-cell suspensions. Cells were expanded in DMEM supplemented with 10% FBS, MEM nonessential amino acids (Life Technologies, Grand Island, NY, USA), L-glutamine (Life Technologies), β-mercaptoethanol (Life Technologies), and gentamycin (Life Technologies). These primary MEFs were then immortalized by using FuGENE 6 (Promega, Madison, WI, USA) to transfect the cells with 1 μg of an expression vector expressing SV40, as described previously. 56 After transfection, cells were maintained in normal growth media. To generate stable MEF lines, retrovirus was produced as described previously. 57 MSCV-IGFP-MII containing helper vector and either no cDNA, WT, or mutant ULK1 were cotransfected into 293T cells by using FuGENE 6; cells were then incubated in DMEM with 10% FBS for 48 h. Supernatant was collected twice daily and used to infect GP+E86 retroviral producer cells in the presence of Polybrene (8 μg/ml). Transduced GP+E86 cells were FACS sorted by the presence of GFP and cell-free supernatant was used to transduce Ulk1 −/− MEFs. MEFs stably expressing the Luc+LC3 and Luc+LC3-G120A constructs (gift from Dr. John Cleveland) 23 and Ulk1 −/− Ulk2shRNA MEFs stably expressing WT or KI ULK1 (from of Dr. Reuben Shaw) 27 were described previously.
Gene silencing and quantitative real-time PCR. WT and Ulk1-deficient MEFs were transfected with pooled nontargeting siRNA (Dharmacon, Lafayette, CO, USA), Atg7 siRNA (Dharmacon), or PARP1 siRNA (Dharmacon) by using Lipofectamine RNAi Max (Life Technologies) according to the manufacturer's protocol. Knockdown was confirmed by RT-qPCR (TaqMan, Life Technologies), immunoblot analyses, or both. Total RNA was isolated from cells by using TRIzol Reagent (Life Technologies). The RT reaction was carried out using the SuperScript III first-strand synthesis kit (Life Technologies) according to the manufacturer's instructions. TaqMan Gene Expression Assays containing FAM-labeled primer/ probe sets specific for Atg7, PARP1, or 18S were obtained from Applied Biosystems (Grand Island, NY, USA). The real-time PCR reactions were performed in a total reaction volume of 25 μl by using FastStart TaqMan Probe Master (Roche, Mannheim, Germany) reagent and results were analyzed by using the iCycler IQ real-time PCR detection system (Bio-Rad, Hercules, CA, USA). Relative expression (log 2 ) was calculated using the Pfaff quantification method 58 after normalization of cycle thresholds to 18S RNA and calibration to respective controls.
Cell viability, ATP, and caspase activity assays. MEFs grown in complete media were washed with DMEM or EBSS and incubated either in DMEM or EBSS supplemented with 10% dialyzed FBS or in DMEM with 500 μM H 2 O 2 for . Transfected cells were treated with 4.5 μM β-lapachone for 72 h and then cell viability was assessed using CellTiter-Glo assays. Signals were normalized to those in DMSO-treated controls (n = 4 biologic replicates per condition), Po0.001. (j) The 293T cells transfected with the indicated expression vectors were arrayed in a 96-well format and treated with either camptothecin for 72 h (starting at a concentration equal to 7 mM followed by threefold dilutions) or DMSO (negative control). Signals (in relative light units, RLUs) from the CellTiter-Glo assays were normalized by subtracting the median RLU of the DMSO control wells and then fit to the four-parameter log-logistic function ('Hill equation') to yield 'activity.' EC 50 : log concentration at half-maximal observed response. The results demonstrate an eightfold difference between the EC 50 of WT ULK1 and that of the R266A-ULK1 mutant. (k) Representative immunoblot showing the levels of ULK1 in cells transfected with the indicated constructs and used for the experiments described in i and j (n = 3 biologic replicates per condition, unless otherwise indicated) Figure 8 Model showing the pro-survival role of cytoplasmic ULK1and the prodeath role of nuclear ULK1. Cytoplasmic ULK1 promotes cell survival by promoting autophagy; by contrast, nuclear ULK1 interacts with PARP1 and promotes its activation in response to oxidative stress, thereby facilitating ATP depletion and necrosis ULK1 regulates PARP1 activity A Joshi et al the indicated times. At the desired intervals, cells were trypsinized and counted by using trypan blue-exclusion assays to determine the percentages of viable and nonviable cells. Cells were also subjected to Annexin V-FITC/PI double staining before flow cytometry. The staining was performed according to the protocol of the manufacturer (BD Pharmingen, San Jose, CA, USA). Flow cytometry was performed using a FACSCalibur (BD Biosciences, San Jose, CA, USA) and results were analyzed using FlowJo V10 (Tree Star, Ashland, OR, USA). Cell viability was also measured using the CellTiter-Glo reagent ('CTG', Promega catalogue number G7573) as per the manufacturer's protocol. Intracellular ATP was measured using the EnzyLight ATP assay kit (BioAssay Systems, Atlanta, GA, USA) or Celltiter Glo (Promega) as per the manufacturer's protocols. The Caspase-Glo 3/7 Luminescent Assay (Promega) was used according to the manufacturer's instructions. In brief, WT and KO MEFs were seeded into 96-well plates (2 × 10 4 cells/well) in triplicate. Then, 1 μM staurosporine and 500 μM H 2 O 2 were added. Caspase activity was detected on a Synergy HT luminometer (BioTek, Winooski, VT).
Luc-LC3 luciferase-degradation assay. Luc-LC3-degradation assays were performed as described previously. 23 Briefly, 1 × 10 4 cells expressing Luc-LC3 or the control Luc-LC3G120A mutant were plated in a 96-well white plate (Costar 3917, Fisher Scientific, Pittsburgh, PA, USA) with a final volume of 100 μl per well. To analyze luciferase activity, an equal volume of BriteLite Plus reagent (Perkin Elmer) was added to all wells and incubated at room temperature for 2 min; the resulting luminescence was measured using an Envision reader (Perkin Elmer) with a dwell time of 0.1 s/well. Resulting data were normalized to the control wells (normal media) by using the formula (100 × experimental/ average (control)), to determine the percentage-control values. To normalize data to the Luc-LC3G120A-negative control, we calculated the ratio of the Luc-LC3 signal (% control) to the Luc-LC3G120A signal (% control).
Western blot analysis and antibodies. Unless otherwise indicated, cells were lysed in modified RIPA buffer (150 mM NaCl, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM EDTA, 50 mM Tris-HCl pH 8.0) supplemented with complete EDTA-free protease-inhibitor cocktails (Sigma-Aldrich) and phosphatase-inhibitor cocktails (Sigma-Aldrich). Cleared lysates were size separated on 4-12% Bis-Tris gels (Invitrogen). Proteins were transferred to either a nitrocellulose or PVDF membrane. After incubation with 5% milk or 5% BSA block, blots were probed with the following antibodies: Flag-M2 (F3165, Sigma-Aldrich), ULK1 (A7481, Sigma-Aldrich), PARP1 (9542, Cell Signaling Technology, Danvers, MA, USA), PAR (ab14459, Abcam, Cambridge, MA, USA), Caspase-3 (8G10, Cell Signaling Technology), and GAPDH (G9545, Sigma-Aldrich). Membranes were then incubated with either of the following: (1) horseradish peroxidase-conjugated secondary antibody, with bands detected by chemiluminescence detection kits (Amersham, Pittsburgh, PA, USA), or (2) secondary antibodies labeled with a 700-or 800-nm channel dye (LI-COR Biosciences, Lincoln, NE, USA), with bands detected by the Odyssey Infrared Imaging System (LI-COR Biosciences). Subcellular fractionation. Subcellular fractionation was conducted as described previously, with slight modifications. 59 Briefly, cells were washed in icecold PBS and lysed by incubation for 10 min in ice-cold hypotonic buffer (10 mM HEPES/KOH pH 7.9, 10 mM KCl, 2 mM MgCl 2 , 0.1 mM EDTA, 1 mM dithiothreitol (DTT), 0.5 mM PMSF, protease inhibitors, and NP-40). The lysates were centrifuged at 13 000 × g for 2 min. The supernatant was stored as the cytoplasmic fraction. The nuclear pellet was washed and nuclear proteins were extracted by incubation on ice for 20 min in cold buffer (20 mM HEPES/KOH pH 7.9, 1.5 mM MgCl 2 , 0.2 mM EDTA, 650 mM NaCl, 25% v/v glycerol, 1 mM DTT, 0.5 mM PMSF, and protease inhibitors). After centrifugation at 13 000 × g for 20 min at 4°C, supernatants containing nuclear proteins were stored.
Immunoprecipitation. For immunoprecipitation (IP) of GFP-or Flag-tagged proteins, 293T cells were transfected with the relevant constructs. After 48 h, cells were lysed with hypotonic lysis buffer (10 mM Tris-HCl pH 7.5, 10 mM NaCl, 2 mM EDTA, 0.5% Triton X-100) supplemented with phosphatase inhibitor (Sigma-Aldrich) and complete EDTA-free protease-inhibitor cocktails (Sigma-Aldrich). Then, 500 μg of lysate was incubated overnight at 4°C with anti-Flag M2 antibody-conjugated beads (Sigma-Aldrich) or anti-GFP antibody-conjugated sepharose beads (ab69314, Abcam). The beads were washed with Net-2 buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05% Triton X-100) and bound proteins were eluted with the Flag peptide (Sigma-Aldrich) or incubated at 95°C for 5 min in SDS sample buffer (Sigma Aldrich).
Endogenous ULK1 was immunoprecipitated from nuclear extracts as described previously. 23 Briefly, after nuclear-protein extraction, lysates were incubated overnight at 4°C with either anti-ULK1 antibody (Santa Cruz, Dallas, TX, USA) or anti-ULK1 antibody preblocked with the ULK1 peptide (Santa Cruz). ULK1 and its interacting partners were precipitated using Protein-G agarose beads (Pierce, Grand Island, NY, USA). The beads were washed five times with NET-2 buffer and incubated at 95°C for 5 min in the sample buffer (Invitrogen).
Proteomics. The MS analysis was performed according to an optimized platform as previously reported. 60 Ulk1-interacting proteins were visualized by performing SYPRO Ruby Protein Gel Staining (Sigma-Aldrich) according to the manufacturer's protocol. Proteins in gel bands were reduced by adding DTT and then alkylated by adding iodoacetamide. The gel bands were then washed, dried in a speed vacuum, and rehydrated with a trypsin-containing buffer for overnight proteolysis. The digested peptides were extracted, dried, reconstituted, and loaded onto a capillary reverse-phase C18 column by an HPLC system (Waters ACQUITY UPLC, Milford, MA, USA). Peptides were eluted in a gradient, ionized by electrospray ionization, and detected using an inline mass spectrometer (Thermo Scientific LTQ Orbitrap Elite, Grand Island, NY, USA). MS spectra were collected and the top 20 abundant ions were sequentially isolated for MS/MS analysis. This process was cycled over the entire liquid chromatography gradient. The acquired MS/MS spectra were used to search protein databases to obtain possible peptide matches. The quality of the IP-MS data were examined and we found that the total spectral counts of three controls and two ULK1-IP were 234, 959, 408, 1064, and 909, respectively. The first control appeared to be an outlier and was therefore removed. Obvious contaminants such as keratin were also deleted from the protein table.
We analyzed the statistically significant protein changes among these IP samples by using a previously published protocol based on G-test. 50 Briefly, the G-value of a given protein was calculated according to the detected spectral counts in any of two samples for comparison. Assuming that the G-values approximately fit the χ 2 distribution (1 degree of freedom), we derived the P-values. We next established a reliable P-value threshold to identify protein changes with statistical significance. Ideally, the threshold should accept a very small number of proteins (i.e., false discoveries) in null experiments (e.g., comparison of technical replicates, control A versus control B, or ULK1A versus ULK1B). When the same threshold is used for control-ULK1 comparisons, the list is deemed acceptable with a low false-discovery rate (FDR). To find the appropriate threshold, we dynamically adjusted the P-value from 0.4 to 0.001 and identified that a P-value of 0.02 was a reasonable threshold with balanced sensitivity and specificity (FDR of~10%, Supplementary Table S1). After manual interpretation, we accepted 14 proteins in the ULK1 IP samples (Supplementary Table S2 ).
Microscopy. For live-cell imaging, cells were incubated with SYTOX green, Hoechst, and Annexin V (Invitrogen) in the presence or the absence of H 2 O 2 as per the manufacturer's protocol. Images were acquired every 15 min for up to 24 h on a Marianas spinning-disk confocal (SDC) imaging system (Intelligent Imaging Innovations/3i, Denver, CO) consisting of a Carl Zeiss Axio Observer motorized inverted microscope (Carl Zeiss MicroImaging, Peabody, MA, USA) equipped with a CSUX SDC head (Yokogowa Electric Corporation, Tokyo, Japan) and a LaserStack (3i), including the lasers 405, 488, and 561 nm. Images were acquired using Zeiss Plan-Apochromat × 63 1.4 NA DIC objectives, an Evolve 512 EMCCD camera (Photometrics, Tucson, AZ, USA), and SlideBook 5.0 software (3i). For nucleolar localization imaging, PARP1-GFP-transfected cells were fixed in 0.25% paraformaldehyde for 15 min without permeabilization. For localization of untagged ULK1, cells were fixed in 4% formaldehyde and permeabilized with digitonin. After being blocked with 1% BSA, cells were stained with an anti-ULK1 antibody and a secondary antibody conjugated to Alexa Fluor 488 or 555 (Invitrogen).
Samples for electron microscopy were fixed in 2.5% glutaraldehyde and 2.0% paraformaldehyde in 0.1 M sodium cacodylate buffer pH 7.4, overnight at 4°C, and processed as described previously. 61 Sections were examined by using a JEOL 1010 electron microscope (JEOL USA, Peabody, MA, USA) fitted with a Hamamatsu digital camera system (Hamamatsu Photonics, Hamamatsu City, Japan).
Fluorescence recovery after photobleaching. Fluorescence recovery after photobleaching (FRAP) experiments were conducted as described previously. 54 FRAP analyses were performed on live WT or Ulk1-deficient MEFs transfected with PARP1-GFP fusion proteins. All photobleaching experiments were performed on a Marianas SDC imaging system (Intelligent Imaging Innovations/3i).
A 488-nm laser and × 63 objective with 1.4 NA were used to acquire FRAP data. Fluorescence recovery was monitored over a 50-s period. Data obtained for recovery were corrected for the background intensity and loss of total fluorescence. Two-photon microirradiation. Laser microirradiation was carried out as previously described. 54 Briefly, cells were grown on coverslips and labeled with 1 μm 5′-bromo-2′-deoxyuridine overnight. Cells were exposed to 1 μg/ml Hoechst 33258 for 1 h and then placed on the stage of a Marianas SDC microscope. Doublestrand breaks (DSBs) were generated along a 1-μm-wide region across the nucleus of a single living cell by using a near-infrared, 780-nm titanium-sapphire laser line to excite the Hoechst 33258 dye. The laser output was set to 10% (unless stated otherwise) and we used 10 iterations to generate localized DSBs that were clearly traceable with a × 40 objective. Protein accumulation within the laser path was compared with that in an undamaged region within the same microirradiated cell. Therefore, each cell provided a reference unirradiated region that provided high sensitivity to detect and measure small changes in the concentration of fluorescently tagged proteins. For microirradiation, we selected cells with low expression levels and normalized the fluorescence intensity in the microirradiated area to the initial fluorescence in the whole nucleus, to compensate for photobleaching during acquisition.
Statistical analyses. All statistical analyses were performed on data from at least three independent experiments. For nucleolar localization, more than 100 cells from 3 independent experiments were counted per condition. Error bars represent S.D. Statistical analysis was performed by using SigmaPlot (Systat Software, Inc., San Jose, CA, USA). Significance was assessed by either one-way ANOVA testing followed by Student-Newman-Keuls post-hoc analysis or by Student's t-testing.
